TTP/HUS and prognosis: the syndrome and the disease(s)
Authors:
- 1 February 2009
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 75 (112) , S59-S61
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006
- Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2005
- Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2005
- The Oklahoma thrombotic thrombocytopenic Purpura-Hemolytic uremic syndrome (TTP-HUS) registry: a community perspective of patients with clinically diagnosed TTP-HUSSeminars in Hematology, 2004
- The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndromeSeminars in Hematology, 2004
- Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experienceSeminars in Hematology, 2004
- ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patientsBlood, 2003
- Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? NoJournal of Thrombosis and Haemostasis, 2003
- Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic SyndromeNew England Journal of Medicine, 1991
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1991